Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Banyu develops factor Xa inhibitors as antiplatelet/antithrombotic agents

April 2, 1998

Preliminary results of TIMI 15A trial reported at ACC

April 1, 1998

Anticoagulants in development at DuPont Merck

April 1, 1998

Potent and selective PDE III inhibitor in development at Otsuka

March 31, 1998

New antiplatelet and antithrombotic agent characterized by Taisho

March 31, 1998

Toyama researchers characterize antiplatelet/antithrombotic effects of T-250

March 31, 1998

Platelet antiaggregatory effects of liposome-encapsulated streptokinase

March 30, 1998

Z-335 demonstrates beneficial effects in models of peripheral circulatory insufficiency

March 30, 1998

DuPont Merck obtains U.S. rights for anticoagulant

March 27, 1998

Selective factor Xa inhibitors in development at Banyu

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...